scholarly article | Q13442814 |
P2093 | author name string | Leo J L D van Griensven | |
Harrie A Verhoeven | |||
P2860 | cites work | The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation | Q24531840 |
Exploring the full spectrum of macrophage activation | Q24653754 | ||
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen | Q28249524 | ||
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) | Q28276146 | ||
Metabolic modulation of glioblastoma with dichloroacetate | Q28282255 | ||
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | Q28287810 | ||
Further evidence to support the melanocytic origin of MDA-MB-435 | Q30857872 | ||
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review | Q34028478 | ||
A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 | ||
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. | Q34355664 | ||
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase | Q34517998 | ||
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. | Q34525433 | ||
False positive and false negative FDG-PET scans in various thoracic diseases | Q36426674 | ||
Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate | Q37316793 | ||
Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate | Q37436821 | ||
Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. | Q39695465 | ||
Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. | Q39700468 | ||
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines | Q39709246 | ||
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo | Q39835139 | ||
Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA. | Q39907305 | ||
Expression of class Pi glutathione transferase in human malignant melanoma cells | Q42155176 | ||
Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation | Q42502038 | ||
Establishment and characterization of three new continuous cell lines derived from human breast carcinomas | Q42802314 | ||
Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. | Q44808698 | ||
Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent. | Q45965442 | ||
Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. | Q48168700 | ||
Hexokinase isozymes in human neoplastic and fetal tissues: The existence of hexokinase II in malignant tumors and in placenta | Q67339548 | ||
The kinetics, substrate, and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells determined using the fluorescent intracellular pH indicator, 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein | Q70889972 | ||
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester | Q72032180 | ||
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm? | Q85217129 | ||
P433 | issue | 1 | |
P921 | main subject | flow cytometry | Q1141429 |
P304 | page(s) | 91-99 | |
P577 | publication date | 2012-02-09 | |
P1433 | published in | Journal of Bioenergetics and Biomembranes | Q5044470 |
P1476 | title | Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis | |
P478 | volume | 44 |
Q54526090 | 3-bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective “small molecule” anti-cancer agent taken from labside to bedside: introduction to a special issue |
Q38847030 | Real-time imaging of microparticles and living cells with CMOS nanocapacitor arrays |
Q38837920 | The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. |
Search more.